Category
If you write anything about cancer treatment, it’s nearly impossible to avoid writing about immunotherapy. But reporting on immunotherapy can…

Over the years, I’ve presented on reporting medical research findings. Some of the most common questions I get are about…

It’s no secret that humans are horrible at comprehending and estimating risk, especially when it comes to abstract numbers. It’s…

I’ve written in previous posts about what to look for in COVID-19 vaccine trials and red flags to monitor. The…

When it comes to feeling competent about understanding, interpreting and reporting on medical studies, one under-appreciated fact is that this…

One of the nation’s most interesting, patient- and media-friendly medical organizations next week will focus on a topic more relevant…

It’s been a dizzying task for reporters trying to keep up with the development of COVID-19 vaccines. There are the…

Francis Collins, director of the National Institutes of Health, will be a featured speaker at the Association of Health Care…

The timeless advice sometimes attributed to Deep Throat or Bob Woodard and Carl Bernstein to “follow the money” certainly applies…

In a previous blog post, I discussed what reporters look for when they dig into the data from the various…
